BioCentury | Mar 2, 2021
Management Tracks

Orphazyme hires Amgen’s Bourdon as CEO; plus Tsang joins Ropes & Gray, and updates from Karolinska, Kadmon, Immunicum, InnoCare, Abivax

...technologies. Rovers replaces Peter Suenaert, who will remain an adviser.Beijing-based cancer and autoimmune disease company InnoCare Pharma Ltd....
...as CMO; she was previously CMO of Versantis AG. BC Staff Orphazyme A/S Karolinska Development AB Kadmon Holdings Inc. Abivax S.A. InnoCare Pharma Ltd. Immunicum...
BioCentury | Feb 4, 2021
Deals

Feb. 3 Quick Takes: Hillhouse takes stakes in InnoCare, Luye; plus Merck KGaA, Inivata, Reverie, Neurocrine, Eisai and more

...By Karen Tkach Tuzman, Senior Editor, And Jeff Cranmer, Executive Editor InnoCare Pharma Ltd. (HKEX:9969) raised HK$3 billion...
...research, development and regulatory milestones, plus royalties. BC Staff Tepmetko (tepotinib, MSC2156119J) Hillhouse Capital Merck KGaA Reverie Labs Inc. Neurocrine Biosciences Inc. InnoCare Pharma Ltd. Eisai...
BioCentury | Jan 29, 2021
Product Development

The TYK2 pipeline: Data Byte

...pan-JAK inhibitors.According to BioCentury’s BCIQ database, the inhibitors from Nimbus, Bristol Myers Squibb Co. (NYSE:BMY), InnoCare Pharma Ltd....
...2 Danielle Golovin deucravacitinib (BMS-986165) Brepocitinib (PF-06700841) PF-06826647 Nimbus-Tyk2-unknown SDC-1801 SAR-20347 Smyraf peficitinib (ASP015K) ICP-332 SDC-1802 Bristol Myers Squibb Co. Pfizer Inc. Nimbus Therapeutics LLC Sareum Holdings plc Astellas Pharma Inc. InnoCare Pharma Ltd. Neuron23...
BioCentury | Jan 8, 2021
Product Development

Jan. 7 Quick Takes: Sarepta tumbles after hours on DMD miss; plus InnoCare, AstraZeneca, Astellas and Autolus

...also will cut headcount by 20%.TARGETSBtk – Bruton’s tyrosine kinaseSGLT2 – Sodium-glucose cotransporter 2 Stephen Hansen RG6356 (SRP-9001, rAAVrh74.MHCK7.micro-Dystrophin) InnoCare Pharma Ltd. Astellas...
BioCentury | May 16, 2020
Finance

HKEX’s biotech chapter shows all the signs of a sustainable market

...sign of a maturing price discovery and valuation process. Deals for Alphamab Oncology Ltd. (HKEX:9966), InnoCare Pharma Ltd....
BioCentury | Apr 23, 2020
Finance

In Hong Kong’s largest biotech IPO of the year, antibody company Akeso raises $333M

...have affected roadshows and slowed offerings (see “Coronavirus Could Stall China IPOs” ). Last month InnoCare Pharma Ltd....
BioCentury | Mar 20, 2020
Finance

Strong investor demand for InnoCare on HK exchange despite pandemic concerns

...top of its proposed range, valuing the company at HK$11.2 billion (US$1.4 billion). Last week, InnoCare Pharma Ltd....
...Kintor Pharmaceutical Ltd. and Immunotech Biopharm Ltd. Targets Btk - Bruton's tyrosine kinase Hongjiang Li, Staff Writer ICP-022 InnoCare Pharma Ltd. Bruton's...
BioCentury | Mar 12, 2020
Finance

March 11 Quick Takes: PDL, Kala, InnoCare, LifeSci, BioSight, BillionToOne, SEC

...disease therapies using its mucus penetrating drug delivery technology. InnoCare sets Hong Kong IPO terms InnoCare Pharma Ltd....
...report to indicate that they will utilize the extension and summarizing why it is needed. BioCentury Staff InnoCare Pharma Ltd. BioSight...
BioCentury | Dec 11, 2019
Financial News

Local demand high for Alphamab Oncology’s Hong Kong IPO

...Kong’s New Chapter" ). While the chapter's IPO queue includes active applications from Akeso Inc., InnoCare Pharma...
BioCentury | Oct 28, 2019
Financial News

After Hong Kong IPO lull, local demand lifts Ascentage offering

...Ltd., Venus Medtech (Hangzhou) Inc., Alphamab Oncology Ltd., SinoMab BioScience Ltd.,Tasly Biopharmaceuticals Co. Ltd. and InnoCare Pharma Ltd....
Items per page:
1 - 10 of 15
BioCentury | Mar 2, 2021
Management Tracks

Orphazyme hires Amgen’s Bourdon as CEO; plus Tsang joins Ropes & Gray, and updates from Karolinska, Kadmon, Immunicum, InnoCare, Abivax

...technologies. Rovers replaces Peter Suenaert, who will remain an adviser.Beijing-based cancer and autoimmune disease company InnoCare Pharma Ltd....
...as CMO; she was previously CMO of Versantis AG. BC Staff Orphazyme A/S Karolinska Development AB Kadmon Holdings Inc. Abivax S.A. InnoCare Pharma Ltd. Immunicum...
BioCentury | Feb 4, 2021
Deals

Feb. 3 Quick Takes: Hillhouse takes stakes in InnoCare, Luye; plus Merck KGaA, Inivata, Reverie, Neurocrine, Eisai and more

...By Karen Tkach Tuzman, Senior Editor, And Jeff Cranmer, Executive Editor InnoCare Pharma Ltd. (HKEX:9969) raised HK$3 billion...
...research, development and regulatory milestones, plus royalties. BC Staff Tepmetko (tepotinib, MSC2156119J) Hillhouse Capital Merck KGaA Reverie Labs Inc. Neurocrine Biosciences Inc. InnoCare Pharma Ltd. Eisai...
BioCentury | Jan 29, 2021
Product Development

The TYK2 pipeline: Data Byte

...pan-JAK inhibitors.According to BioCentury’s BCIQ database, the inhibitors from Nimbus, Bristol Myers Squibb Co. (NYSE:BMY), InnoCare Pharma Ltd....
...2 Danielle Golovin deucravacitinib (BMS-986165) Brepocitinib (PF-06700841) PF-06826647 Nimbus-Tyk2-unknown SDC-1801 SAR-20347 Smyraf peficitinib (ASP015K) ICP-332 SDC-1802 Bristol Myers Squibb Co. Pfizer Inc. Nimbus Therapeutics LLC Sareum Holdings plc Astellas Pharma Inc. InnoCare Pharma Ltd. Neuron23...
BioCentury | Jan 8, 2021
Product Development

Jan. 7 Quick Takes: Sarepta tumbles after hours on DMD miss; plus InnoCare, AstraZeneca, Astellas and Autolus

...also will cut headcount by 20%.TARGETSBtk – Bruton’s tyrosine kinaseSGLT2 – Sodium-glucose cotransporter 2 Stephen Hansen RG6356 (SRP-9001, rAAVrh74.MHCK7.micro-Dystrophin) InnoCare Pharma Ltd. Astellas...
BioCentury | May 16, 2020
Finance

HKEX’s biotech chapter shows all the signs of a sustainable market

...sign of a maturing price discovery and valuation process. Deals for Alphamab Oncology Ltd. (HKEX:9966), InnoCare Pharma Ltd....
BioCentury | Apr 23, 2020
Finance

In Hong Kong’s largest biotech IPO of the year, antibody company Akeso raises $333M

...have affected roadshows and slowed offerings (see “Coronavirus Could Stall China IPOs” ). Last month InnoCare Pharma Ltd....
BioCentury | Mar 20, 2020
Finance

Strong investor demand for InnoCare on HK exchange despite pandemic concerns

...top of its proposed range, valuing the company at HK$11.2 billion (US$1.4 billion). Last week, InnoCare Pharma Ltd....
...Kintor Pharmaceutical Ltd. and Immunotech Biopharm Ltd. Targets Btk - Bruton's tyrosine kinase Hongjiang Li, Staff Writer ICP-022 InnoCare Pharma Ltd. Bruton's...
BioCentury | Mar 12, 2020
Finance

March 11 Quick Takes: PDL, Kala, InnoCare, LifeSci, BioSight, BillionToOne, SEC

...disease therapies using its mucus penetrating drug delivery technology. InnoCare sets Hong Kong IPO terms InnoCare Pharma Ltd....
...report to indicate that they will utilize the extension and summarizing why it is needed. BioCentury Staff InnoCare Pharma Ltd. BioSight...
BioCentury | Dec 11, 2019
Financial News

Local demand high for Alphamab Oncology’s Hong Kong IPO

...Kong’s New Chapter" ). While the chapter's IPO queue includes active applications from Akeso Inc., InnoCare Pharma...
BioCentury | Oct 28, 2019
Financial News

After Hong Kong IPO lull, local demand lifts Ascentage offering

...Ltd., Venus Medtech (Hangzhou) Inc., Alphamab Oncology Ltd., SinoMab BioScience Ltd.,Tasly Biopharmaceuticals Co. Ltd. and InnoCare Pharma Ltd....
Items per page:
1 - 10 of 15